Cargando…

Prediction of Absorbed Dose to Normal Organs with Endocrine Tumors for I-131 by use of (99m)TC Single Photon Emission Computed Tomography/Computed Tomography and Geant4 Application for Tomographic Emission Simulation

INTRODUCTION: This study aimed to predict the dose absorbed by normal organs with neuroendocrine tumors for (131)I using single photon emission computed tomography/computed tomography (SPECT/CT) images and Geant4 application for tomographic emission (GATE) simulation. MATERIALS AND METHODS: Four to...

Descripción completa

Detalles Bibliográficos
Autores principales: Asl, Rohollah Ghahraman, Sabbaghi, Rezvan, Ahangari, Hadi Taleshi, Hejazi, Payman, Foroutan, Majid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8481846/
https://www.ncbi.nlm.nih.gov/pubmed/34658551
http://dx.doi.org/10.4103/ijnm.ijnm_6_21
Descripción
Sumario:INTRODUCTION: This study aimed to predict the dose absorbed by normal organs with neuroendocrine tumors for (131)I using single photon emission computed tomography/computed tomography (SPECT/CT) images and Geant4 application for tomographic emission (GATE) simulation. MATERIALS AND METHODS: Four to 5 whole-body planar scan series, along with one SPECT/CT image, were taken from four patients following (99m)Tc-hynic-Tyr(3)-octreotide radiotracer injection. After image quantification, the residence time of each organ was calculated using the image analysis and the activity time curves. The energy deposit and dose conversion (S-value) were extracted from the GATE simulation for the target organs of each patient. Using the residence times and S-values, the mean absorbed dose for the target organs of each patient was calculated and compared with the data obtained from the standard method. RESULTS: Very close agreement was obtained between the S-value of the self–organ irradiation. The mean percentage difference between the two methods (i.e. GATE and Medical Internal Radiation Dose [MIRD]) was 1.8%, while a weak agreement was observed for cross-organ irradiation. The percentage difference between the total absorbed doses by the organs was 2%. The percentage difference between the absorbed doses obtained for tumors and three considered normal organs estimated by the GATE method was slightly higher than the MIRD method (about 11% on average for tumors). CONCLUSION: Regardless of the small difference between the obtained results for the organs and absorbed doses of the tumors in the present study, patient-specific dosimetry by the GATE methods is useful and essential for therapeutic radionuclides such as (131)I due to high cross-dose effects, especially for young adult patients, to ensure the radiation safety and increase the effectiveness of the treatment.